Anti-CHODL monoclonal antibody

Pre-made anti-CHODL monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CHODL/CHODL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0542-Ab-1/ GM-Tg-hg-IP0542-Ab-2Anti-Human CHODL monoclonal antibodyHuman
GM-Tg-rg-IP0542-Ab-1/ GM-Tg-rg-IP0542-Ab-2Anti-Rat CHODL monoclonal antibodyRat
GM-Tg-mg-IP0542-Ab-1/ GM-Tg-mg-IP0542-Ab-2Anti-Mouse CHODL monoclonal antibodyMouse
GM-Tg-cynog-IP0542-Ab-1/ GM-Tg-cynog-IP0542-Ab-2Anti-Cynomolgus/ Rhesus macaque CHODL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0542-Ab-1/ GM-Tg-felg-IP0542-Ab-2Anti-Feline CHODL monoclonal antibodyFeline
GM-Tg-cang-IP0542-Ab-1/ GM-Tg-cang-IP0542-Ab-2Anti-Canine CHODL monoclonal antibodyCanine
GM-Tg-bovg-IP0542-Ab-1/ GM-Tg-bovg-IP0542-Ab-2Anti-Bovine CHODL monoclonal antibodyBovine
GM-Tg-equg-IP0542-Ab-1/ GM-Tg-equg-IP0542-Ab-2Anti-Equine CHODL monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0542-Ab-1/ GM-Tg-hg-IP0542-Ab-2; GM-Tg-rg-IP0542-Ab-1/ GM-Tg-rg-IP0542-Ab-2;
GM-Tg-mg-IP0542-Ab-1/ GM-Tg-mg-IP0542-Ab-2; GM-Tg-cynog-IP0542-Ab-1/ GM-Tg-cynog-IP0542-Ab-2;
GM-Tg-felg-IP0542-Ab-1/ GM-Tg-felg-IP0542-Ab-2; GM-Tg-cang-IP0542-Ab-1/ GM-Tg-cang-IP0542-Ab-2;
GM-Tg-bovg-IP0542-Ab-1/ GM-Tg-bovg-IP0542-Ab-2; GM-Tg-equg-IP0542-Ab-1/ GM-Tg-equg-IP0542-Ab-2
Products NameAnti-CHODL monoclonal antibody
Formatmab
Target NameCHODL
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CHODL monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0542-Ag-1Recombinant multi-species CHODL/ C21orf68/ MT75 protein


    Target information

    Target IDGM-IP0542
    Target NameCHODL
    Gene ID140578,246048,288289,716237,487699,101089132,613942,100053952
    Gene Symbol and Synonyms3110074E07Rik,C21orf68,CHODL,MT75,PRED12
    Uniprot AccessionQ9H9P2
    Uniprot Entry NameCHODL_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000154645
    Target ClassificationN/A

    The target: CHODL, gene name: CHODL, also named as C21orf68, MT75, PRED12. This gene encodes a type I membrane protein with a carbohydrate recognition domain characteristic of C-type lectins in its extracellular portion. In other proteins, this domain is involved in endocytosis of glycoproteins and exogenous sugar-bearing pathogens. This protein localizes predominantly to the perinuclear region. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Feb 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.